Expression of Chemokine Receptors on Peripheral Blood T Cells in Children with Chronic Kidney Disease
Table 3
Percentage values of T cell subpopulations, including populations with expression of receptors for selected chemokines in examined children and healthy controls.
Lymphocyte subpopulations %]
HD group
CKD group
Control group
T lymphocytes
71,0 (53,4–90,1)
69,9 (49,8–89,9)
69,3 (36,7–91,9)
0,2903
CD4+ T cells
41,8 (15,2–55,5)
36,6 (20–54,8)
34,2 (11,4–58,0)
0,3171
CD8+ T cells
31,2 (13,5–45,0)
30,7 (15,5–45,4)
22,2 (8,4–42,1)
0,0001
CCR7+ T cells
15,4 (2,1–33,7)
18,1 (5,3–30,1)
2,4 (0,3–49,6)
0,0052
CD45RO+CCR7+
2,4 (0,4–10,1)
3,1 (0,6–21,2)
0,9 (0,3–21,2)
0,3274
CD28+CCR7+ T cells
15,1 (2,1–32,4)
16,5 (4,9–29,5)
2,6 (0,3–48,5)
0,0412
CXCR4+ T cells
10,6 (1,3–45,9)
23,1 (4,4–45,5)
14,4 (2,9–60,1)
0,1030
CXCR4+CD4+ T cells
2,6 (0,001–31,7)
6,5 (0,3–24,3)
5,5 (0,0004–38,7)
0,4996
CXCR4+CD8+ T cells
6,7 (1,3–21,3)
15,0 (3,1–29,1)
7,0 (1,1–32,0)
0,0233
CXCR4+CCR5+ T cells
0,8 (0,001–8,5)
2,5 (0,6–17,9)
2,5 (0,0002–26,0)
0,0795
CCR5+ T cells
13,0 (3,6–26,9)
15,1 (5,1–30,3)
12,8 (2,2–53,0)
0,4015
CCR5+CD4+ T cells
3,2 (1,3–5,6)
3,4 (1,4–5,6)
3,4 (0,6–9,5)
0,6438
CCR5+CD8+ T cells
7,4 (1,7–21,7)
9,3 (2,6–18,7)
5,8 (1,1–41,3)
0,9799
CCR4+ T cells
5,0 (0,3–22,3)
6,0 (0,8–33,6)
7,5 (1,0–31,6)
0,6464
CCR4+CD4+ T cells
4,4 (0,9–47,3)
4,5 (1,7–12,3)
5,7 (0–15,9)
0,2978
CCR4+CD8+ T cells
2,0 (0,002–14,2)
1,1 (0,001–34,3)
0,9 (0,0002–24,7)
0,7969
CXCR3+ T cells
31,8 (14,8–42,7)
30,6 (18,7–43,3)
23,4 (11,3–48,8)
0,9798
CXCR3+CD4+ T cells
10,7 (4,9–18,1)
10,0 (4,5–19,3)
9,3 (1,7–17,0)
0,5450
CXCR3+CD8+ T cells
14,4 (8,5–33,2)
17,1 (8,9–26,7)
16,5 (7,2–27,8)
0,8588
CXCR3+CCR5+ T cells
10,6 (3,1–23,4)
11,8 (4,1–26,6)
6,9 (1,3–26,9)
0,2822
CXCR3+CXCR4+ T cells
7,4 (0,7–20,3)
14,3 (2,1–26,9)
5,9 (1,0–15,9)
0,1994
Percentage values are shown as median value (minimum–maximum). : significance in ANOVA test.
